Josue Ocasio Tapia
Internal Medicine · San Juan, PRNPI 1932683562
Payments from drug & device makers
Across 116 payments — averaging $37.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$959
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$625
- E.r. Squibb & Sons, L.L.C.$527
- Medtronic$328
- Amgen$281
- Johnson & Johnson$263
- plus $1K from 12 others
What the payments were for
- Food & beverage$4,17596%
- Education$1904%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $959 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 30 | $625 |
| E.r. Squibb & Sons, L.L.C. | 16 | $527 |
| Medtronic | 4 | $328 |
| Amgen | 6 | $281 |
| Johnson & Johnson | 5 | $263 |
| Bayer | 2 | $245 |
| PBG Puerto Rico LLC | 12 | $214 |
| Novartis | 8 | $161 |
| AstraZeneca | 2 | $141 |
| Boehringer Ingelheim | 6 | $133 |
| Lilly USA, LLC | 1 | $119 |
| Bridgebio Pharma, Inc. | 1 | $105 |
| Merck | 5 | $95 |
| Scpharmaceuticals Inc. | 4 | $83 |
| Chiesi USA, Inc. | 2 | $33 |
| Dexcom, Inc. | 1 | $28 |
| Bayer Puerto Rico Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$244
- LifeVest$200
- ONYX FRONTIER$155
- GENERAL BRADY$138
- GENERAL TACHY$136
- WATCHMAN FLX$125
- ACCOLADE SR$125
- FARXIGA$122
- ZEPBOUND$119
- Repatha$119
- Attruby$105
How this compares
$4,365 in reported general payments places this provider in the 90th percentile of 1,043 internal medicine providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 21 | $15,406 |
| EliquisApixaban | 25 | $14,744 |
| Metoprolol Succinate | 20 | $173 |
| Atorvastatin Calcium | 19 | $133 |
| Lisinopril | 19 | $87 |
| Carvedilol | 16 | $84 |
| Amlodipine Besylate | 14 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $133 | $15,40621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,043 internal medicine providers in Puerto Rico.
Other internal medicine in San Juan
- Grisell Ortiz LasantaSan Juan$5.9M
- Ricardo FernandezSan Juan$480K
- Pedro del Valle de TomasSan Juan$114K
- Norma SalgadoSan Juan$21K
- Victor Gordo GonzalezSan Juan$21K
- Roberto Calderon SantiagoSan Juan$20K
- Natalia Almodovar ArbeloSan Juan$9K
- Jeremy FelicianoSan Juan$8K
- Porfirio Diaz-RodriguezSan Juan$8K
- Rafael Figueroa NavarroSan Juan$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.